Peter Marks to Join Thursday Hot Topic Discussion on Individual Risk Assessment

February 01, 2023

Peter Marks, MD, PhD, director of FDA’s Center for Biologics Evaluation and Research, will join an AABB Hot Topic Discussion from 2-3 p.m. ET on Thursday to discuss FDA’s recent draft guidance on individual risk assessment.

Following Marks’ presentation, Sharon Carayiannis, MT(ASCP)HP, AABB’s vice president of science and practice, will moderate a question-and-answer session. AABB is accepting questions from the community until 2 p.m. ET today.

Registration is complimentary but required.